Healthcare provider profile · identity verified

Mohammad Ibrahim, MD

Allopathic & Osteopathic Physicians|Internal Medicine · BROOKSVILLE, FL · NPI 1992725048

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Mohammad Ibrahim, MD received $120.21 in general payments during 2025 across 1 reported records.

E.R. Squibb & Sons, L.L.C. accounted for 100.0% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 1 associated product.

E.R. Squibb & Sons, L.L.C. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 27956 records involving 14870 distinct recipient NPIs. Public Medicare Part D data also shows 598 claims for Eliquis by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$120.21

1 reported records · 1 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
E.R. Squibb & Sons, L.L.C.	Unresolved — no canonical attribution shown	$120.21	100.0%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$120.21	1

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
OPDIVO Normalized: opdivo	Biological	E.R. Squibb & Sons, L.L.C.	$120.21	1	2025
Source payment records 2025-05-28 · E.R. Squibb & Sons, L.L.C. · $120.21 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
E.R. Squibb & Sons, L.L.C. Exact reporting entity; no affiliate inference	2025	ELIQUIS open payments reported associated product	CMS Open Payments — General Payments 27956 supporting records · 14870 recipient NPIs · example record 1184377713	Eliquis · 2024 Exact normalized brand match · 1 Part D row	598	96

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Eliquis	Apixaban	598	96
Atorvastatin Calcium	Atorvastatin Calcium	588	146
Furosemide	Furosemide	483	101
Levothyroxine Sodium	Levothyroxine Sodium	463	77
Metoprolol Tartrate	Metoprolol Tartrate	327	85
Gabapentin	Gabapentin	309	88
Clopidogrel	Clopidogrel Bisulfate	300	90
Tamsulosin Hcl	Tamsulosin Hcl	283	61
Lisinopril	Lisinopril	262	62
Divalproex Sodium	Divalproex Sodium	252	45
Potassium Chloride	Potassium Chloride	248	65
Amlodipine Besylate	Amlodipine Besylate	240	72
Losartan Potassium	Losartan Potassium	211	64
Trazodone Hcl	Trazodone Hcl	198	57
Pantoprazole Sodium	Pantoprazole Sodium	189	64
Sertraline Hcl	Sertraline Hcl	187	48
Carvedilol	Carvedilol	146	36
Metformin Hcl	Metformin Hcl	146	37
Mirtazapine	Mirtazapine	125	34
Oxycodone Hcl	Oxycodone Hcl	119	105
Baclofen	Baclofen	109	19
Levetiracetam	Levetiracetam	103	21
Metoprolol Succinate	Metoprolol Succinate	101	35
Donepezil Hcl	Donepezil Hcl	98	22
Ropinirole Hcl	Ropinirole Hcl	98	18
Duloxetine Hcl	Duloxetine Hcl	97	26
Escitalopram Oxalate	Escitalopram Oxalate	97	24
Glipizide	Glipizide	95	21
Carbidopa-Levodopa	Carbidopa/Levodopa	94	15
Levofloxacin	Levofloxacin	85	61
Omeprazole	Omeprazole	85	34
Methenamine Hippurate	Methenamine Hippurate	82	18
Spironolactone	Spironolactone	79	22
Isosorbide Mononitrate Er	Isosorbide Mononitrate	77	18
Quetiapine Fumarate	Quetiapine Fumarate	77	25
Midodrine Hcl	Midodrine Hcl	76	25
Hydrochlorothiazide	Hydrochlorothiazide	72	26
Montelukast Sodium	Montelukast Sodium	72	18
Ondansetron Hcl	Ondansetron Hcl	72	34
Atenolol	Atenolol	71	16
Oxybutynin Chloride	Oxybutynin Chloride	71	19
Buspirone Hcl	Buspirone Hcl	69	30
Rosuvastatin Calcium	Rosuvastatin Calcium	69	20
Citalopram Hbr	Citalopram Hydrobromide	67	22
Prednisone	Prednisone	66	27
Amiodarone Hcl	Amiodarone Hcl	59	28
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	59	29
Paroxetine Hcl	Paroxetine Hcl	58	suppressed
Ceftriaxone	Ceftriaxone Sodium	57	33
Tizanidine Hcl	Tizanidine Hcl	57	13
Ciprofloxacin Hcl	Ciprofloxacin Hcl	56	30
Nystatin	Nystatin	55	18
Benztropine Mesylate	Benztropine Mesylate	54	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	53	16
Allopurinol	Allopurinol	52	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	50	41
Fluoxetine Hcl	Fluoxetine Hcl	49	14
Simvastatin	Simvastatin	48	14
Lovastatin	Lovastatin	47	suppressed
Ertapenem	Ertapenem Sodium	46	29
Doxazosin Mesylate	Doxazosin Mesylate	44	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	43	27
Meloxicam	Meloxicam	42	13
Tramadol Hcl	Tramadol Hcl	42	16
Pravastatin Sodium	Pravastatin Sodium	41	11
Clonidine Hcl	Clonidine Hcl	40	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	40	suppressed
Hydralazine Hcl	Hydralazine Hcl	40	14
Isosorbide Dinitrate	Isosorbide Dinitrate	40	suppressed
Alendronate Sodium	Alendronate Sodium	39	suppressed
Azithromycin	Azithromycin	39	30
Lamotrigine	Lamotrigine	39	suppressed
Olanzapine	Olanzapine	39	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	39	suppressed
Lidocaine	Lidocaine	38	suppressed
Ranolazine Er	Ranolazine	38	suppressed
Risperidone	Risperidone	38	13
Dexamethasone	Dexamethasone	37	27
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	37	14
Metolazone	Metolazone	36	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	35	suppressed
Promethazine Hcl	Promethazine Hcl	35	23
Finasteride	Finasteride	34	13
Perphenazine	Perphenazine	33	suppressed
Digoxin	Digoxin	32	suppressed
Lactulose	Lactulose	32	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	32	suppressed
Memantine Hcl	Memantine Hcl	32	14
Doxycycline Hyclate	Doxycycline Hyclate	31	20
Entresto	Sacubitril/Valsartan	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Terazosin Hcl	Terazosin Hcl	31	suppressed
Sucralfate	Sucralfate	30	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	29	20
Xarelto	Rivaroxaban	29	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Lithium Carbonate	Lithium Carbonate	27	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	27	suppressed
Bumetanide	Bumetanide	26	suppressed
Glipizide Er	Glipizide	26	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	26	11
Mupirocin	Mupirocin	26	12
Primidone	Primidone	26	suppressed
Chlorthalidone	Chlorthalidone	25	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	25	suppressed
Meclizine Hcl	Meclizine Hcl	25	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	24	15
Cilostazol	Cilostazol	24	suppressed
Fluconazole	Fluconazole	24	19
Fluticasone Propionate	Fluticasone Propionate	24	14
Brilinta	Ticagrelor	23	suppressed
Famotidine	Famotidine	23	14
Memantine Hcl Er	Memantine Hcl	23	suppressed
Movantik	Naloxegol Oxalate	23	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	23	suppressed
Methylprednisolone	Methylprednisolone	22	19
Ammonium Lactate	Ammonium Lactate	21	suppressed
Carbamazepine	Carbamazepine	21	suppressed
Ondansetron Odt	Ondansetron	21	suppressed
Oxcarbazepine	Oxcarbazepine	21	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	17
Ketoconazole	Ketoconazole	20	suppressed
Lidocaine Hcl	Lidocaine Hcl	20	14
Metronidazole	Metronidazole	19	11
Topiramate	Topiramate	19	suppressed
Vascepa	Icosapent Ethyl	19	suppressed
Cefdinir	Cefdinir	18	11
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	18	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Gemtesa	Vibegron	18	suppressed
Insulin Aspart	Insulin Aspart	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Trintellix	Vortioxetine Hydrobromide	18	suppressed
Vancomycin Hcl	Vancomycin Hcl	18	suppressed
Bupropion Hcl	Bupropion Hcl	17	suppressed
Diltiazem Hcl	Diltiazem Hcl	17	11
Fluvoxamine Maleate	Fluvoxamine Maleate	17	suppressed
Irbesartan	Irbesartan	17	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Linezolid	Linezolid	17	12
Nitroglycerin	Nitroglycerin	17	suppressed
Sodium Chloride	0.9 % Sodium Chloride	17	suppressed
Solu-Medrol	Methylprednisolone Sod Succ/Pf	17	suppressed
Sulfasalazine Dr	Sulfasalazine	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Insulin Lispro	Insulin Lispro	16	suppressed
Novolog	Insulin Aspart	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	15	suppressed
Folic Acid	Folic Acid	15	suppressed
Labetalol Hcl	Labetalol Hcl	15	suppressed
Levocarnitine	Levocarnitine	15	suppressed
Mesalamine	Mesalamine	15	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	15	suppressed
Phenytoin	Phenytoin	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Calcitriol	Calcitriol	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Levemir Flexpen	Insulin Detemir	14	suppressed
Calcium Acetate	Calcium Acetate	13	suppressed
Cholestyramine	Cholestyramine (With Sugar)	13	suppressed
Clozapine	Clozapine	13	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Methotrexate	Methotrexate Sodium	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Valsartan	Valsartan	12	suppressed
Albuterol Sulfate	Albuterol Sulfate	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$120.21 · 1 records	E.R. Squibb & Sons, L.L.C.	OPDIVO	1	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with E.R. Squibb & Sons, L.L.C.?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error